policy
We want you! My Neuro Survey is now open
22 July 2024 People living with neurological conditions across the UK and Ireland are being asked to take part in the largest neurological survey to help improve vital services and support. The Neurological Alliance – a leading coalition of over 90 charities working to transform quality of life for people with neurological conditions – runs My […]
Neurological Alliance launches #NeuroChampion campaign ahead of UK 2024 General Election
As the UK prepares for the upcoming General Election on 4 July 2024, The Neurological Alliance and our members are launching a pivotal campaign to call on future MPs to use their voice to improve treatment, care, support and research for people affected by neurological conditions. Parliamentary support has never been more needed The #NeuroChampion […]
NHS England Operational Planning Guidance for 24/25 published
Last week, just days before the new financial year, NHS England published its Priorities and Operational planning guidance for 2024/25. You can read the full document here. The document outlines key priorities for NHS spending and focus for the year ahead. The guidance is important, as it sets out key areas of activity for the […]
Neurological conditions leading cause of ill health and disability globally
New research published in The Lancet Neurology has confirmed that neurological conditions are now the leading cause of ill health and disability globally. More than four in 10 of the world population lived with a neurological condition in 2021, approximately 3.4 billion people. 443 million years of healthy life lost Researchers calculated the overall “burden” […]
New research shows that implementing existing solutions could reduce the financial impact of neurological conditions by £30 billion
New research released this week shows that neurological conditions are costing the UK 4.3% of its GDP, equivalent to £96 billion a year.1 The report, produced by The Economist Impact Unit and commissioned by pharmaceutical company Roche, suggests that implementing existing interventions could reduce the financial impact of these conditions by £30.8 billion.1 Implementing existing […]
Published: new optimal clinical pathways for neurological conditions
New optimal clinical pathways of care have been published for a range of neurological conditions, including epilepsy and neurological autoimmune diseases, and crosscutting pathways for neurogenetics and rehabilitation for adults with neurological conditions. Access the pathways here. The pathways set out what good treatment, care and support looks like. This includes treatment and support for […]
